NORBEL Business Summary

Norbel Baby Co., Ltd. (6844.TWO), operating primarily under the prominent "Tin Tin Drugstore" (Ding Ding Pharmacy) brand, is a leading Taiwanese retail pharmacy chain specializing in a transaction-based revenue model. The company's business is diversified across four primary segments: maternity and infant products (including milk powder and diapers), prescription and over-the-counter pharmaceuticals, health supplements and medical supplies for aging populations, and medical beauty products. Norbel differentiates itself through a large-format store strategy and the provision of professional pharmaceutical consulting services. In the competitive landscape, it contends directly with Great Tree Pharmacy, MedFirst Healthcare Services, and Simple Mart Retail. Following its strategic acquisition by the Qisda Group, Norbel has transitioned from a traditional maternal-infant specialist into a comprehensive healthcare platform, currently ranking as one of Taiwan's top five professional pharmacy and medical supply providers by store count and market influence. The company was founded in 1986 and has been led for nearly three decades by CEO Wang-Shen Hsu, who maintains a significant ownership stake and provides long-term operational continuity. Since late 2024, the leadership structure has been significantly influenced by its controlling shareholder, Qisda Corporation (2352.TW), which holds an ownership stake exceeding 40%. Consequently, the board is chaired by Peter Chen (Chen Chi-hong), the Chairman of Qisda, who has integrated Norbel into a broader healthcare ecosystem that includes BenQ Medical Center and various medical device subsidiaries. Other major shareholders and board-level interests include Chu Hsiang Investment Co., Ltd. and Tin Tin T.T. Enterprise Co., Ltd., reflecting a mix of original founding interests and modern corporate backing from Taiwan's high-tech manufacturing sector.